Solid Tumors
Clinical Study To Further Evaluate The Efficacy Of Dabrafenib Plus Trametinib In Patients With Rare BRAF V600E Mutation-Positive Unresectable or Metastatic Solid Tumors (CDRB436IIC01)
- Details
ClinicalTrials.gov ID:
NCT05868629
Diagnosis Type:
NA
USOR Number:
- Address
,
P: